Clinical trial
Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating…
NCT00074191 · OHSU Knight Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00074191 |
|---|---|
| Title | Methotrexate, Procarbazine, Lomustine, Dexamethasone, and Cytarabine in Treating Patients With Primary CNS Lymphoma |
| Official title | Combination Chemotherapy (Methotrexate, Procarbazine And CCNU), Intraventricular Cytarabine And Methotrexate, +/- Intra-Ocular Chemotherapy For Patients With Primary Central Nervous System Lymphoma |
| Acronym | Protocol-A |
| Lead sponsor | OHSU Knight Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Drug |
| Interventions | cytarabine, dexamethasone, lomustine, methotrexate, procarbazine hydrochloride |
| Enrollment | 1 |
| Start date | Jan 1, 2000 |
| Primary completion | Oct 1, 2000 |
| Completion | Oct 1, 2000 |
| First posted | Dec 11, 2003 |
| Last update posted | Apr 21, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: